Altered MEF2 isoforms in myotonic dystrophy and other neuromuscular disorders
Authors:
- 22 November 2010
- journal article
- research article
- Published by Wiley in Muscle & Nerve
- Vol. 42 (6) , 856-863
Abstract
Because of their central role in muscle development and maintenance, MEF2 family members represent excellent candidate effectors of the muscle pathology in myotonic dystrophy (DM). We investigated the expression and alternative splicing of all four MEF2 genes in muscle from neuromuscular disorder (NMD) patients, including DM1 and DM2. We observed MEF2A and MEF2C overexpression in all NMD muscle, including 12 MEF2‐interacting genes. Exon 4 and 5 usage in MEF2A and MEF2C was different between DM and normal muscle, with DM showing the embryonic isoform. Similar splicing differences were observed in other NMD muscle. For MEF2C, missplicing was more pronounced in DM than in other dystrophies. Our data confirm dysregulation of MEF2A and MEF2C expression and splicing in several NMD, including DM. Our findings demonstrate that aberrant splicing in NMD is independent from expression of mutant repeats, and suggests that some aberrant splicing, even in DM, may be compensatory rather than primary. Muscle Nerve 42: 856–863, 2010Keywords
This publication has 42 references indexed in Scilit:
- Aberrant alternative splicing and extracellular matrix gene expression in mouse models of myotonic dystrophyNature Structural & Molecular Biology, 2010
- Transcriptional and post-transcriptional impact of toxic RNA in myotonic dystrophyHuman Molecular Genetics, 2009
- Global analysis of aberrant pre-mRNA splicing in glioblastoma using exon expression arraysBMC Genomics, 2008
- MEF2: a central regulator of diverse developmental programsDevelopment, 2007
- Stem and Progenitor Cells in Skeletal Muscle Development, Maintenance, and TherapyMolecular Therapy, 2007
- Extracellular Matrix Gene Alternative Splicing by Trabecular Meshwork Cells in Response to Mechanical StretchingInvestigative Ophthalmology & Visual Science, 2007
- Atherosclerosis-related molecular alteration of the human CaV1.2 calcium channel α1CsubunitProceedings of the National Academy of Sciences, 2006
- Alterations of Sodium Channel Kinetics and Gene Expression in the Postinfarction Remodeled MyocardiumJournal of Cardiovascular Electrophysiology, 2001
- TRANSCRIPTIONAL CONTROL OF MUSCLE DEVELOPMENT BY MYOCYTE ENHANCER FACTOR-2 (MEF2) PROTEINSAnnual Review of Cell and Developmental Biology, 1998
- Reemergence of the Fetal Pattern of L-Type Calcium Channel Gene Expression in Noninfarcted Myocardium during Left Ventricular RemodelingBiochemical and Biophysical Research Communications, 1995